Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

EFFECTOR THERAPEUTICS, INC.

(EFTR)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op EFFECTOR THERAPEUTICS, INC.
2021EFFECTOR THERAPEUTICS, INC.(NASDAQCM : EFTR) added to S&P TMI Index
2021INSIDER SELL : Effector Therapeutics
2021EFFECTOR Therapeutics Says Preclinical Data Shows Anti-Tumor Potential of Zotatifin; Sh..
2021eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers ..
2021EFFECTOR Therapeutics, Inc. Announces Publication of Zotatifin Preclinical Data in Fron..
2021eFFECTOR Therapeutics to Participate in The JMP Securities Hematology and Oncology Summ..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021EFFECTOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Conditio..
2021EFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corpora..
2021EFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corpora..
2021Earnings Flash (EFTR) EFFECTOR THERAPEUTICS Reports Q3 Revenue $0.4M
2021EFFECTOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
2021EFFECTOR Appoints Barbara Klencke, M.D., to Board of Directors
2021Onyx Pharmaceuticals, Inc. Announces Board Changes
2021eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
2021EFFECTOR THERAPEUTICS : Reports New Data on Preclinical Studies of Zotatifin to Treat Brea..
2021Top Premarket Gainers
2021EFFECTOR THERAPEUTICS : Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed P..
2021Baylor College of Medicine Presents eFFECTOR Therapeutics-Backed Preclinical Data Suppo..
2021EFFECTOR THERAPEUTICS : Baylor College of Medicine to Present eFFECTOR Therapeutics-Suppor..
2021EFFECTOR THERAPEUTICS : to Participate in 2021 Cantor Virtual Healthcare Conference
2021EFFECTOR THERAPEUTICS : Shares Soar Amid Heavy Trading Volume
2021EFFECTOR THERAPEUTICS : Changes in Registrant's Certifying Accountant, Amendments to Artic..
2021LOCT WALK : Unaudited condensed financial information of Old eFFECTOR as of and for the th..
2021EFFECTOR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K..
2021Top Premarket Decliners
2021SECTOR UPDATE : Health Care Stocks Largely Down This Afternoon
2021Top Midday Gainers
2021LOCUST WALK ACQUISITION : Shares Surge After Shareholders Approve Pending Merger With eFFE..
2021Wall Street in Holding Pattern, Stabilizing in Run-Up to Jackson Hole
2021US Futures Stabilize in Jackson Hole Run-Up
2021Top Premarket Gainers
2021LOCUST WALK ACQUISITION CORP.(NASDAQ : LWAC) dropped from NASDAQ Composite Index
2021LOCUST WALK ACQUISITION : Stockholders Approve Business Combination with eFFECTOR Therapeu..
2021EFFECTOR Therapeutics, Inc. completed the acquisition of Locust Walk Acquisition Corp. ..
2021LOCUST WALK ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other..
2021LOCUST WALK ACQUISITION : Shareholders Approve Combination with eFFECTOR Therapeutics
2021LOCUST WALK ACQUISITION CORP. : Other Events (form 8-K)
2021LOCUST WALK ACQUISITION : Merger Agreement (Form 8-K)
2021LOCUST WALK ACQUISITION : Management's Discussion and Analysis of Financial Condition and ..
2021Locust Walk Acquisition Corp. Announces Earnings Results for the Second Quarter Ended J..
2021LOCUST WALK ACQUISITION : EFFECTOR Therapeutics Announces Publication of Tomivosertib Prec..
2021LOCUST WALK ACQUISITION : Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Co..
2021EFFECTOR Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
2021LOCUST WALK ACQUISITION : Related to Delayed Filing of Quarterly Report on Form 10-Q Stemm..
2021LOCUST WALK ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued List..
2021LOCUST WALK ACQUISITION : Management's Discussion and Analysis of Financial Condition and ..
2021Locust Walk Acquisition Corp. Reports Earnings Results for the First Quarter Ended Marc..
2021LOCUST WALK ACQUISITION : Effector Therapeutics to Go Public in Merger With Special-Purpos..
2021LOCUST WALK ACQUISITION : EFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce..
2021LOCUST WALK ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered S..
2021LOCUST WALK ACQUISITION : EFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce..
2021EFFECTOR Therapeutics, Inc. entered into a Letter of intent to acquire Locust Walk Acqu..
2021LOCUST WALK ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
2021Locust Walk Acquisition Corp. Reports Earnings Results for the Fourth Quarter Ended Dec..
2021LOCUST WALK ACQUISITION CORP.(NASDAQ : LWAC) added to NASDAQ Composite Index
2021Locust Walk Acquisition Corp. announced that it has received $5.45 million in funding f..
2021Locust Walk Acquisition Corp. has completed an IPO in the amount of $153 million.
2020Locust Walk Acquisition Corp. has filed an IPO in the amount of $130 million.
2020Locust Walk Acquisition Corp. announced that it expects to receive $5.2 million in fund..